Polystyrene Ramp & Margin Resilience Test
After a stellar Q1 (revenue +22%, EBITDA +188%), Supreme Petrochem reports Q2 FY27 results on October 23. The Street will watch whether margin momentum persists amid commodity headwinds and track early signals from the 80,000 TPA polystyrene expansion announced in July.
What to Expect: The Margin Question
Supreme Petrochem delivered a blowout Q1 FY27: revenue ₹1,693 Cr (+22% YoY) and operating EBITDA ₹331 Cr—a staggering +188% jump—on margins of 19.53%. For Q2, the Street watches whether that margin performance holds or compresses back toward historical levels. A strong print sustains momentum into FY27 full-year guidance (consensus: ₹5.58k Cr revenue +3.3%; EPS ₹21.70 +20.1% growth). A weak print signals commodity pressure or product mix headwinds returning.
~₹1,650 Cr
Trajectory: Q1 momentum suggests mid-to-high ₹1,600s; FY27 guidance implies modest quarterly growth
~18–19%
Q1's 19.53% was exceptional; normalization expected unless specialty-polymer mix improves
Early signals
₹325 Cr expansion into 80k TPA announced July 27—expect board to comment on ramp timeline and margin uplift phasing
Interim dividend
Board meeting Oct 23 will consider interim dividend—management confidence on FCF and cash position
A strong Q2 holds margins above 18%, revenue steady-to-up YoY, and EBITDA in the ₹300+ Cr range. It signals commodity and product mix are holding and management execution on the polystyrene ramp is on track. A weak Q2 sees margins drift to 16–17%, EBITDA below ₹300 Cr, or guidance revision—indicating headwinds in commodity prices, customer offtake, or unforeseen capex timing.
On Track to Guidance?
FY27 consensus estimates ₹5.58k Cr revenue (+3.3% YoY) and EPS ₹21.70 (+20.1%)—a modest top-line growth outlook but profit uplift-led. Q1's +22% revenue and +188% EBITDA were outside the normal run-rate, so Q2 will be the first proof of whether those numbers were a spike or a step-change. If Q2 sustains high-20s EBITDA margins and revenue stays in the ₹1,650+ range, full-year guidance looks intact. If Q2 normalizes harder, the ₹5.58k Cr and 20%+ EPS growth looks aggressive.
Since Last Quarter: Key Filings & Corporate Actions
1 · Polystyrene expansion: 80,000 TPA, ₹325 Cr capex (July 27, 2026)
Supreme Petrochem approved a significant capacity addition into specialty polystyrene at its Amdoshi Complex. Polystyrene commands higher margins than commodity polymers (e.g., LDPE, PP in commodity mode)—the ramp and early-stage execution will be a key focus for investors. No timeline committed publicly; Q2 earnings call will likely offer color on construction progress and margin accretion phasing.
2 · Interim dividend expected (October 23, 2026)
Board meeting on result day will consider an interim dividend. A declared interim signals confidence in FY27 cash flows and earnings trajectory. Management would not commit shareholder cash unless it believes full-year results and FCF justify the distribution—a signal worth parsing on the call.
3 · Trading window closure (September 23, 2026)
Designated persons and promoters closed their trading window ahead of Q2 result—routine governance. No material insider activity or pledges reported in recent quarters; ownership remains stable (promoter 64.24%, FII 3.80%, DII 4.14% as of Q1 FY27).
4 · ESG rating upgrades (July–August 2026)
Company received independent ESG ratings from CRISIL and NSE. No material operational impact; typical for mid-cap petrochemical firms as ESG disclosure becomes standard practice.
What to Watch on October 23
Q2 FY27 results will be released after market hours on October 23. Here are three things to focus on:
1 · Q2 EBITDA margin and YoY profit growth
The headline: did margins stabilize above 18%, or did commodity/mix pressure pull them back to 15–17%? Q1's 188% EBITDA growth was exceptional. Q2 will show whether management can sustain exceptional margins or if the quarter normalizes. The margin trajectory feeds directly into FY27 full-year earnings estimates.
2 · Polystyrene capex execution & margin phasing
Management must comment on the ₹325 Cr polystyrene expansion: construction progress, expected commissioning timeline (late FY27? FY28?), and expected margin uplift from the specialty-polymer mix. Investors want visibility on when this capex translates to earnings accretion.
3 · FY27 guidance reaffirmation & dividend detail
Will management reaffirm ₹5.58k Cr full-year revenue and the implied 20%+ EPS growth? Will the interim dividend be substantial (confident) or minimal (hedging)? Guidance clarity and dividend size will be watched for confidence signals on 2H FY27 and industry outlook.
Supreme Petrochem heads into Q2 FY27 earnings on the back of an exceptional Q1—one that raised the bar for expectation-setting. The Street, with modest coverage and a Hold consensus, is waiting to see if the company can sustain margin momentum, execute on the higher-margin polystyrene ramp, and reaffirm a FY27 guidance that implies continued profit growth. The stock sits oversold (RSI 25.6) and well below recent highs, so a confident Q2—stable-to-strong margins, capex clarity, and a credible dividend—could reignite momentum. A disappointing Q2 or weak guidance would validate the recent pullback.
Watch margin stability, polystyrene timelines, and the dividend decision. The result will set the tone for FY27 earnings expectations and shape the capex-driven story into next fiscal.